Like most websites, we use cookies and other similar technologies for a number of reasons, such as keeping our website reliable and secure, personalizing content, providing social media features and to better understand how our site is used. By using our site, you are agreeing to our use of these tools. Learn More

Your Location is set to:

Clinical Trials Search Results

Showing 1-8 of 8

Sorted By:

  • ADEPT

    To evaluate 3-year invasive disease-free survival in patients with stage I HR+ HER2+ breast cancer treated with adjuvant HP plus endocrine therapy.

  • BIOSPECIMEN COLLECTION STUDY

    A biospecimen collection study for patients diagnosed with certain types of cancer or are scheduled for diagnostic testing.

  • CAMBRIA-1

    This clinical trial aims to improve cancer free-survival in patients with hormone positive early breast with intermediate to high risk for disease recurrence after locoregional and systemic therapy with the next generation oral selective estrogen receptor degrader (SERD), Camizestrant.

  • CompassHER2 Residual Disease for Breast Cancer

    A clinical trial to determine if invasive disease free survival with Kadcyla and tucatinib is superior to Kadcyla and placebo when given to high risk patients with HER2 positive breast cancer and residual disease after HER2-directed therapy.

  • Connect Multiple Myeloma

    A disease registry for patients with relapsed/refractory multiple myeloma.

  • CONNECT MYELOID

    A disease registry for patients with newly diagnosed LR-MDS, treated LR-MDS or MF.

  • PREDICT-RT

    This clinical trial compares de-intensification therapy vs. intensification therapy in high risk prostate cancer.

  • PROACT-Lung

    A observational study to evaluate the performance of the FMBT-Lung (blood test) in screening eligible participants for lung cancer.